|
DE3508258A1
(de)
*
|
1985-03-08 |
1986-09-18 |
Bayer Ag, 5090 Leverkusen |
Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
|
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
US5591762A
(en)
|
1991-02-06 |
1997-01-07 |
Dr. Karl Thomae Gmbh |
Benzimidazoles useful as angiotensin-11 antagonists
|
|
DE4225756A1
(de)
|
1992-01-22 |
1994-03-10 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4224752A1
(de)
|
1992-04-11 |
1994-02-03 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5125961A
(en)
|
1991-08-12 |
1992-06-30 |
Monsanto Company |
Substituted pyridine compounds
|
|
DE4219534A1
(de)
|
1992-02-19 |
1993-12-16 |
Thomae Gmbh Dr K |
Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4408497A1
(de)
|
1994-03-14 |
1995-09-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JPH10503768A
(ja)
|
1994-08-02 |
1998-04-07 |
メルク シヤープ エンド ドーム リミテツド |
アゼチジン、ピロリジンおよびピペリジン誘導体
|
|
RU2135493C1
(ru)
|
1995-04-21 |
1999-08-27 |
Нюросерч А/С |
Производное бензимидазола, фармацевтический состав и способ модуляции гамка-рецепторного комплекса
|
|
JP2000072675A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
AU760250B2
(en)
|
1998-12-04 |
2003-05-08 |
Neurosearch A/S |
New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
|
|
US6380235B1
(en)
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
|
US6664252B2
(en)
*
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
WO2001057019A1
(en)
|
2000-02-01 |
2001-08-09 |
Cor Therapeutics, Inc. |
INDALONE AND BENZIMIDAZOLONE INHIBITORS OF FACTOR Xa
|
|
US20120028912A1
(en)
|
2000-02-22 |
2012-02-02 |
J.David Gladstone Institute |
Methods of modulating bromodomains
|
|
KR100855893B1
(ko)
|
2000-10-27 |
2008-09-03 |
다우 아그로사이언시즈 엘엘씨 |
치환된 4,5-디하이드로-1,2,4-트리아진-6-온,1,2,4-트리아진-6-온 및 살균제 및 살충제로서의 이들의 용도
|
|
IL155962A0
(en)
*
|
2000-12-01 |
2003-12-23 |
Osi Pharm Inc |
Compounds specific to adenosine a1, a2a, and a3 receptors and uses thereof
|
|
IL157638A0
(en)
|
2001-03-01 |
2004-03-28 |
Shionogi & Co |
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
|
|
EP1370557B1
(en)
*
|
2001-03-09 |
2005-11-16 |
Pfizer Products Inc. |
Benzimidazole anti-inflammatory compounds
|
|
EP1370265B8
(en)
|
2001-03-15 |
2013-10-30 |
Janssen Pharmaceutica NV |
Hiv inhibiting pyrazinone derivatives
|
|
JP4329003B2
(ja)
*
|
2001-03-23 |
2009-09-09 |
バイエル コーポレイション |
Ｒｈｏキナーゼ阻害剤
|
|
US7081454B2
(en)
*
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
KR20030083016A
(ko)
|
2001-03-28 |
2003-10-23 |
브리스톨-마이어스스퀴브컴파니 |
신규 타이로신 카이나제 억제제
|
|
US20050176858A1
(en)
|
2002-02-15 |
2005-08-11 |
Bridgestone Corporation |
Rubber composition and pneumatic tire made therefrom
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
WO2004043913A2
(en)
|
2002-11-08 |
2004-05-27 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AR043063A1
(es)
|
2002-12-13 |
2005-07-13 |
Altana Pharma Ag |
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
|
|
AR042956A1
(es)
*
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
CL2004000409A1
(es)
*
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
|
EP1620413A2
(en)
|
2003-04-30 |
2006-02-01 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
|
AU2004263190A1
(en)
|
2003-08-08 |
2005-02-17 |
Avanir Pharmaceuticals |
Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
|
|
NL1026826C2
(nl)
|
2003-08-13 |
2007-01-04 |
Pharmacia Corp |
Gesubstitueerde pyridinonen.
|
|
WO2005080380A1
(en)
|
2004-02-03 |
2005-09-01 |
Eli Lilly And Company |
Kinase inhibitors
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
CN1285590C
(zh)
|
2004-02-23 |
2006-11-22 |
上海医药工业研究院 |
伊曲康唑盐酸盐口服固体组合物和制备方法
|
|
CN1934092A
(zh)
|
2004-03-23 |
2007-03-21 |
弗·哈夫曼-拉罗切有限公司 |
非核苷逆转录酶抑制剂
|
|
US20080015196A1
(en)
|
2004-04-16 |
2008-01-17 |
Neurogen Corporation |
Imidazopyrazines, Imidazopyridines, and Imidazopyrimidines as Crf1 Receptor Ligands
|
|
NZ551775A
(en)
|
2004-06-01 |
2010-12-24 |
Univ Virginia |
Dual small molecule inhibitors of cancer and angiogenesis
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
WO2006021886A1
(en)
|
2004-08-26 |
2006-03-02 |
Pfizer Inc. |
Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
CA2584485C
(en)
|
2004-10-20 |
2013-12-31 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
JP5048520B2
(ja)
|
2005-02-04 |
2012-10-17 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
Ｅ１活性化酵素の阻害剤
|
|
MX2007011234A
(es)
*
|
2005-03-14 |
2007-11-12 |
Transtech Pharma Inc |
Derivados de benzazol, composiciones y metodos de uso en la forma de inhibidores de b-secretasa.
|
|
CN101189214A
(zh)
|
2005-05-03 |
2008-05-28 |
美国陶氏益农公司 |
取代的4，5-二氢-1，2，4-三嗪-6-酮、1，2，4-三嗪-6-酮及其作为杀菌剂的用途
|
|
JP5368792B2
(ja)
|
2005-07-29 |
2013-12-18 |
レスバーロジックス コーポレイション |
複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
|
|
KR20080068839A
(ko)
|
2005-10-03 |
2008-07-24 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 화합물 및 그 의약 용도
|
|
US20070197532A1
(en)
|
2005-11-18 |
2007-08-23 |
Cao Sheldon X |
Glucokinase activators
|
|
DE602006011363D1
(de)
*
|
2005-12-01 |
2010-02-04 |
Hoffmann La Roche |
Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
|
|
CN101384593A
(zh)
*
|
2006-02-17 |
2009-03-11 |
辉瑞有限公司 |
用作tlr7调节剂的3-脱氮嘌呤衍生物
|
|
JP2009528989A
(ja)
*
|
2006-02-17 |
2009-08-13 |
ファイザー・リミテッド |
Ｔｌｒ７変調剤としての３−デアザプリン誘導体
|
|
WO2007117465A2
(en)
*
|
2006-03-31 |
2007-10-18 |
Abbott Laboratories |
Indazole compounds
|
|
AU2007233715A1
(en)
|
2006-04-03 |
2007-10-11 |
Glaxo Group Limited |
Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors
|
|
CA2700988A1
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
CN102442941A
(zh)
|
2006-12-14 |
2012-05-09 |
安斯泰来制药有限公司 |
用作crth2拮抗剂和抗过敏剂的多环酸化合物
|
|
SG144809A1
(en)
*
|
2007-01-11 |
2008-08-28 |
Millipore U K Ltd |
Benzimidazole compounds and their use as chromatographic ligands
|
|
DK2118074T3
(en)
|
2007-02-01 |
2014-03-10 |
Resverlogix Corp |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
BRPI0811065A2
(pt)
*
|
2007-06-08 |
2014-12-02 |
Abbott Lab |
Indazóis 5-heteroaril substituídos como inibidores de quinase
|
|
AU2008267444A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
GB0719235D0
(en)
|
2007-10-02 |
2007-11-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
CA2708262A1
(en)
|
2007-12-07 |
2009-06-18 |
Elan Pharmaceuticals, Inc. |
Methods and compositions for treating liquid tumors
|
|
US8084466B2
(en)
|
2007-12-18 |
2011-12-27 |
Janssen Pharmaceutica Nv |
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
|
|
US8476260B2
(en)
|
2007-12-28 |
2013-07-02 |
Mitsubishi Tanabe Pharma Corporation |
Antitumor agent
|
|
TW200942537A
(en)
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009158258A1
(en)
|
2008-06-25 |
2009-12-30 |
E. I. Du Pont De Nemours And Company |
Herbicidal dihydro oxo six-membered azinyl isoxazolines
|
|
PE20110368A1
(es)
*
|
2008-08-18 |
2011-06-13 |
Univ Yale |
Moduladores de mif
|
|
US9540322B2
(en)
*
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
AU2009324894B2
(en)
|
2008-11-25 |
2015-04-09 |
University Of Rochester |
MLK inhibitors and methods of use
|
|
EP2370413B1
(en)
|
2008-12-08 |
2015-08-05 |
Arena Pharmaceuticals, Inc. |
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
DE102008062826A1
(de)
|
2008-12-23 |
2010-07-01 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
US8389550B2
(en)
|
2009-02-25 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
|
|
EP2406236A4
(en)
|
2009-03-09 |
2013-07-24 |
Surface Logix Inc |
RHO KINASE INHIBITORS
|
|
KR101709492B1
(ko)
|
2009-03-18 |
2017-02-23 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
US8975247B2
(en)
|
2009-03-18 |
2015-03-10 |
The Board Of Trustees Of The Leland Stanford Junion University |
Methods and compositions of treating a flaviviridae family viral infection
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
WO2010127976A1
(en)
|
2009-05-05 |
2010-11-11 |
F. Hoffmann-La Roche Ag |
Isoxazole-pyridine derivatives
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
EP2496580B1
(en)
|
2009-11-05 |
2013-12-11 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
|
SI2496582T1
(sl)
|
2009-11-05 |
2016-04-29 |
Glaxosmithkline Llc Corporation Service Company |
Benzodiazepinski inhibitor bromodomene
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
*
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2011062437A2
(ko)
|
2009-11-20 |
2011-05-26 |
에스케이케미칼주식회사 |
고나도트로핀 방출 호르몬 수용체 길항제, 이의 제조방법 및 이를 함유하는 약제학적 조성물
|
|
JP2013512880A
(ja)
*
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
KR101165996B1
(ko)
|
2010-04-23 |
2012-07-18 |
주식회사 녹십자 |
프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
MX384074B
(es)
|
2010-05-14 |
2025-03-12 |
Dana Farber Cancer Inst Inc |
Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
|
|
JP2011246389A
(ja)
*
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有する縮環ピラゾール誘導体
|
|
WO2011156626A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
WO2011159926A1
(en)
|
2010-06-16 |
2011-12-22 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2803448A1
(en)
|
2010-07-06 |
2012-01-12 |
Universite De Montreal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
WO2012021382A1
(en)
|
2010-08-12 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
KR101242572B1
(ko)
|
2010-10-12 |
2013-03-19 |
한국화학연구원 |
5-환 헤테로 아릴로 치환된 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CN102731409A
(zh)
|
2011-04-08 |
2012-10-17 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物，其药物组合物、制备方法及用途
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
JP5878178B2
(ja)
*
|
2011-09-30 |
2016-03-08 |
大鵬薬品工業株式会社 |
１，２，４−トリアジン−６−カルボキサミド誘導体
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
ES2648340T3
(es)
|
2011-12-01 |
2018-01-02 |
Chemocentryx, Inc. |
Benzoimidazoles y benzopirazoles substituidos como antagonistas de CCR(4)
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
CA2874303C
(en)
|
2012-06-11 |
2020-10-13 |
Ucb Biopharma Sprl |
Tnf -alpha modulating benz imidazoles
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
CN104780764A
(zh)
|
2012-09-05 |
2015-07-15 |
拜尔农作物科学股份公司 |
取代的2-酰氨基苯并咪唑、2-酰氨基苯并噁唑和2-酰氨基苯并噻唑或其盐作为活性物质对抗非生物植物胁迫的用途
|
|
WO2014043246A1
(en)
|
2012-09-11 |
2014-03-20 |
The Board Of Trustees Of The University Of Illinois |
Enoyl reductase inhibitors with antibacterial activity
|
|
ES2625945T3
(es)
|
2012-11-14 |
2017-07-21 |
Glaxosmithkline Llc |
Tieno[3,2-c]piridin-4(5H)-onas como inhibidores de bet
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US20150344444A1
(en)
|
2012-12-20 |
2015-12-03 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroxyquinoxalinones
|
|
US9271978B2
(en)
|
2012-12-21 |
2016-03-01 |
Zenith Epigenetics Corp. |
Heterocyclic compounds as bromodomain inhibitors
|
|
JP2016513117A
(ja)
|
2013-02-22 |
2016-05-12 |
バイエル ファーマ アクチエンゲゼルシャフト |
過剰増殖性疾患を治療するためのｂｅｔタンパク質阻害剤としてのピロロ−およびピラゾロ−トリアゾロジアゼピン類
|
|
HK1212345A1
(en)
|
2013-02-22 |
2016-06-10 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
JP6404838B2
(ja)
|
2013-02-27 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ブロモドメイン阻害剤として有用なカルバゾール化合物
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤およびこれを用いる治療方法
|
|
EP2970285B1
(en)
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
JP2016512524A
(ja)
|
2013-03-11 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害剤
|
|
WO2014165143A1
(en)
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone bromodomain inhibitors
|
|
WO2014165127A1
(en)
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Pyrrole amide inhibitors
|
|
JP6280573B2
(ja)
|
2013-03-14 |
2018-02-14 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
ブロモドメイン阻害薬としてのフロピリジン
|
|
ES2704048T3
(es)
|
2013-03-14 |
2019-03-14 |
Glaxosmithkline Ip No 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina-2,3-disustituida y su uso como inhibidores de bromodominio
|
|
WO2014159837A1
(en)
|
2013-03-14 |
2014-10-02 |
Convergene Llc |
Methods and compositions for inhibition of bromodomain-containing proteins
|
|
WO2014152029A2
(en)
|
2013-03-15 |
2014-09-25 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
HRP20181392T1
(hr)
|
2013-03-15 |
2018-10-19 |
Plexxikon Inc. |
Heterociklični spojevi i njihova uporaba
|
|
US9227985B2
(en)
|
2013-03-15 |
2016-01-05 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
EP2978757B1
(en)
|
2013-03-27 |
2017-02-08 |
Boehringer Ingelheim International GmbH |
Indolinone analogues as brd4 inhibitors
|
|
US9199988B2
(en)
|
2013-03-27 |
2015-12-01 |
Boehringer Ingelheim International Gmbh |
Dihydroquinazolinone analogues
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
WO2014170350A1
(en)
|
2013-04-17 |
2014-10-23 |
Albert Ludwigs Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EP2792355A1
(en)
|
2013-04-17 |
2014-10-22 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
WO2014173241A1
(en)
|
2013-04-26 |
2014-10-30 |
Beigene, Ltd. |
Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
CA2913697A1
(en)
|
2013-05-27 |
2014-12-04 |
Novartis Ag |
Imidazopyrrolidinone derivatives and their use in the treatment of disease
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
CN105492436A
(zh)
|
2013-06-17 |
2016-04-13 |
拜耳制药股份公司 |
取代的苯基-2,3-苯并二氮杂环庚三烯
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
SG11201510409QA
(en)
*
|
2013-06-21 |
2016-01-28 |
Zenith Epigenetics Corp |
Novel bicyclic bromodomain inhibitors
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
US20160272635A1
(en)
|
2013-07-23 |
2016-09-22 |
Bayer Pharma Aktiengesellschaft |
Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinases
|
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
AU2014298051B2
(en)
|
2013-07-31 |
2018-11-15 |
Zenith Epigenetics Ltd. |
Novel quinazolinones as bromodomain inhibitors
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
WO2015074081A1
(en)
|
2013-11-18 |
2015-05-21 |
Bair Kenneth W |
Benzopiperazine compositions as bet bromodomain inhibitors
|
|
PT3071203T
(pt)
|
2013-11-18 |
2021-03-11 |
Forma Therapeutics Inc |
Composições de tetra-hidroquinolina como inibidores de bromodomínio bet
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
WO2016087942A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Corp. |
Substituted pyridines as bromodomain inhibitors
|
|
WO2016087936A1
(en)
|
2014-12-01 |
2016-06-09 |
Zenith Epigenetics Corp. |
Substituted pyridinones as bromodomain inhibitors
|
|
CN107207474B
(zh)
|
2014-12-11 |
2021-05-07 |
恒翼生物医药科技(上海)有限公司 |
被取代的杂环作为溴结构域抑制剂
|
|
CA2966450A1
(en)
|
2014-12-17 |
2016-06-23 |
Olesya KHARENKO |
Inhibitors of bromodomains
|
|
WO2016097870A1
(en)
|
2014-12-17 |
2016-06-23 |
Zenith Epigenetics Corp. |
Substituted bicyclic compounds as bromodomain inhibitors
|